{"nct_id":"NCT03203876","title":"A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2017-07-14","start_date_type":"ACTUAL","primary_completion_date":"2020-08-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}